Microbial Fermentation and the Future of Food. A European Patent Perspective
Protein foods as future strength of the European food sector
Europe seeks to strengthen biotechnology and biomanufacturing as drivers of competitiveness and sustainable growth. Launched in July 2025, the European Commission’s Strategy for European Life Sciences provides a coordinated approach to turning research on living systems into practical applications across healthcare, agriculture, food and other sectors.
Food-system innovation forms part of this broader European ambition. Food 2030 is the EU’s research and innovation policy framework for sustainable, healthy and inclusive food systems. In a whole-system approach, it connects primary production with processing, packaging, distribution, consumption and recycling. Food 2040 builds on this foundation as the food-systems framework within the EU’s strategic approach to agricultural and food research and innovation towards 2040. It places emphasis on translating scientific advances into practical solutions through investment, commercial scale-up and wider market uptake.
Meanwhile, consumer demand for high-protein foods is accompanied by growing patent activity, accompanied by a steady increase in number of patent applications in this area in the recent years. Yet the European agenda extends beyond protein content: diversifying protein sources sits alongside broader goals for healthier diets and more sustainable, resilient food systems.
Sustainable food protein from microbial fermentation
Microbial fermentation offers new ways to produce familiar food proteins and other functional ingredients. Precision fermentation uses microorganisms to manufacture specific target substances, rather than transforming raw ingredients into foods such as yogurt or beer through traditional fermentation. In biomass fermentation, the microorganisms themselves are grown and harvested as a food source.
As food production faces pressure to reduce its environmental footprint and use resources more efficiently, fermentation offers a promising way to address these challenges by producing food proteins through alternative processes. Food protein production by fermentation has the potential to reduce land and water use and greenhouse gas emissions compared with conventional animal-based protein production. By using microorganisms to produce protein traditionally obtained from animals, it removes the need to raise and feed livestock for protein and addresses animal-welfare concerns alongside environmental goals. Environmental benefits of fermentation can be strengthened through sustainable feedstocks and efficient energy use in heating, cooling, agitation and downstream processing.
The interest in fermentation technology is reflected in global market growth projections for fermentation for alternative protein, with estimates suggesting expansion from $61.4 billion in 2026 to over $330,000 billion by 20351.
Patent strategy for microbial fermentation: from production organism to finished food
For food-tech companies developing fermentation technologies, patent protection is often not simply a question of protecting a new protein or micro-organism. The strategic issue is where to build protection along the path from production organism to finished food.
Potential protection can cover the food protein itself, particularly when it has a previously unknown and/or modified sequence. But what if the protein already exists in nature? The position is more challenging where the protein sequence is already known and the protein has previously been available in isolated form.
In Europe, biological material such as proteins and microbial strains isolated from its natural environment or produced through a technical process is not excluded from patentability even if it occurs naturally, if it can be shown to produce an advantageous technical effect. A mere amino acid sequence of a previously known protein without indication of a function thus is not a patentable invention. An example given in EPO’s Guidelines is a substance occurring in nature which is found to have an antibiotic effect. For a food protein, such an advantageous effect could be, for example, improving nutrition or improved functional properties of the protein which can be reflected in the selected claim language.
Microbial strains may also be protected by patents in Europe, with the provision that the strain is isolated, properly deposited and identified in the application by the appropriate deposit number. As with food proteins an advantageous technical effect must be demonstrated for the strain.
Protection may additionally or alternatively focus on a protein or a microbial biomass product, or a food composition containing the protein or biomass. Such claims typically need to be defined by a technically meaningful parameter range and require an advantageous technical effect determinable for the product or composition. Patent claims may also be directed to a microorganism and/or an expression system for producing a food protein. Methods of purifying the protein or biomass or using the protein or biomass in food manufacture may also be a target for protection.
Thus, even where the protein or biomass itself cannot be patented, new products or production methods, host organisms, expression systems, purification processes and food applications may offer opportunities for protection. The aim is to identify the technical contribution and select claim categories that capture it. These different aspects may support several patent families rather than a single application.
Supporting patent claims: the importance of data-backed technical teaching
Fermentation products that qualify as novel foods generally require authorisation before entering the EU market under Regulation (EU) 2015/2283. This involves scientific and safety data addressing both the production organism and the resulting substance. The extent of the assessment depends, among other things, on the organism’s Qualified Presumption of Safety (QPS) status and how well the target protein is characterised.
Patent applications serve a different purpose and may not require data as detailed as those needed for regulatory authorisation. Nevertheless, evidence and experiments are important in supporting patentability.
To be patentable, an invention must meet the requirements of novelty, inventive step and industrial applicability. In addition, the patent application must sufficiently disclose the invention, meaning that the description must enable the skilled person to perform the invention across the whole scope claimed. The EPO also considers plausibility: whether the application makes the asserted technical effect credible and whether the invention solves the technical problem across the whole scope of the claims. Plausibility is not a separate legal requirement expressly set out in the European Patent Convention, but an evaluative standard developed through case law.
In practice, broad claims cannot rest on mere assumptions. Supporting data must make the claimed technical effect credible and demonstrate that the invention can be worked across the whole scope claimed. For example, where claims are defined by parameter ranges or a selection of compounds, the data must demonstrate that those features produce the claimed effect. Broad parameter-defined claims therefore require a sound, comparative data-supported technical teaching in the application.
By way of example, although the decision T 1065/23 (22 May 2025) of the EPO Board of Appeal (BoA) does not directly address fermented proteins or microbial biomass, it offers useful insight into the role of plausibility and supporting data in securing patent protection.
T 1065/23 relates to a European patent claiming a method for extracting pea protein and the protein extract obtainable by the method. The patent was maintained, as the method and product-by-process claims were deemed novel and to involve an inventive step. The BoA found that the method gave unique physicochemical properties of low nitrogen solubility, viscosity, and gel strength to the protein extract product, and that the patent credibly demonstrated these features. The BoA also deemed that the pH range of the method claim was not arbitrary because the patent included data demonstrating that selecting the particular pH range showed a clear technical advantage compared to pH values outside the range.
T 1065/23 thus highlights the importance of including a robust data-supported technical teaching in the patent application. For fermentation-based food inventions, the practical lesson from T 1065/23 is to make the asserted technical advantage credible and enable the invention to be carried out across the full scope of the claims.
Key takeaways
Microbial fermentation could help strengthen Europe’s food sector by diversifying protein sources and supporting more sustainable production. For companies developing precision- or biomass-fermentation technologies, patent opportunities may extend beyond the protein or the biomass itself to production organisms, expression systems, processing methods and food applications. Effective protection depends on identifying the technical contribution and supporting the claimed scope with a sound technical teaching and appropriate data.
- Fermentation for Alternative Protein Market Size, Share, Growth, And Industry Analysis by Type (Precision fermentation, Biomass fermentation, Traditional fermentation) by Application (Online, Offline) Regional Forecast From 2026 To 2035. Report ID: BRI102474 Source: https://www.businessresearchinsights.com/market-reports/fermentation-for-alternative-protein-market-102474. Accessed on 9 Nov 2026.
Latest blog articles
Microbial Fermentation and the Future of Food. A European Patent Perspective
From idea to market – which patent analysis do you need?
A drafting checklist for chemical and pharmaceutical applications
Egg carton illustrates how to package inventions for the Unified Patent Court
When a Descriptive Trademark Comes at a Cost: The SÄHKÖMESSUT Case
Writer